Scholarly EP023 - Past, Present, and Future of Riluzole in Acute SCI with Dr. Michael Fehlings

Join us this episode for a conversation with Dr. Michael Fehlings, the most cited neurosurgeon ever on the topic of spinal cord injury (https://doi.org/10.1038/s41393-021-00691-9), for a conversation about the pharmaceutical agent riluzole for the treatment of acute spinal cord injury (SCI). Dr. Fehlings walks us through the past, present, and future of this drug that has proven efficacy in other neurological conditions and that might serve an important role in initial phases of treating SCI. We trust you'll enjoy this conversation about riluzole from the source of a principal investigator physician-scientist studying it from its inauguration in SCI.

Om Podcasten

The American Spinal Injury Association (ASIA) brings you SCI Science Perspectives. The podcast is built around two-part dialogues with spinal cord injury (SCI) professionals regarding their emerging scientific work spanning the full spectrum of SCI research, from discovery to clinical application. The SCI Science Perspectives podcast disseminates the latest-and-greatest scientific work in the SCI field via a conversation with researchers that approaches their work from two perspectives: the “scholarly” perspective and the “community” perspective. The process begins with ASIA’s Committees informing the podcast about new and influential scientific papers relevant to the committee’s interests. Then the podcast host(s) then interview the author(s) of the papers, approaching their project from each perspective. Finally, the conversation from each perspective is published as its own episode type: "Scholarly" and "Community" episodes. Keep an eye out too for "Admin" episodes too, communicating administrative information relevant to ASIA members and stakeholders.